<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39355615</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Low brain-derived neurotrophic factor and high vascular cell adhesion molecule-1 levels are associated with chronic kidney disease in patients with type 2 diabetes mellitus.</ArticleTitle><Pagination><StartPage>1403717</StartPage><MedlinePgn>1403717</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1403717</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2024.1403717</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Patients with type 2 diabetes mellitus (DM) have a high prevalence of chronic kidney disease (CKD). Energy imbalance and inflammation may be involved in the pathogenesis of CKD. We examined the effects of brain-derived neurotrophic factor (BDNF) and vascular cell adhesion molecule-1 (VCAM-1) on CKD in patients with type 2 DM.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients with type 2 DM were enrolled for this cross-sectional study. Fasting serum was prepared to measure the BDNF and VCAM-1 levels. An estimated glomerular filtration rate (eGFR) &lt;60 mL/min/1.73 m<sup>2</sup> was used as the criterion for identifying patients with CKD.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of the 548 enrolled participants, 156 had CKD. Patients with CKD exhibited significantly lower BDNF (median of 21.4 ng/mL, interquartile range [IQR]: 17.0-27.0 ng/mL vs. median of 25.9 ng/mL, IQR: 21.0-30.4 ng/mL, <i>P &lt;</i>0.001) and higher VCAM-1 (median of 917 ng/mL, IQR: 761-1172 ng/mL vs. median of 669 ng/mL, IQR: 552-857 ng/mL, <i>P &lt;</i>0.001) levels than those without CKD. Serum BDNF levels were inversely correlated with VCAM-1 levels (Spearman's rank correlation coefficient = -0.210, <i>P &lt;</i>0.001). The patients were divided into four subgroups based on median BDNF and VCAM-1 levels (24.88 ng/mL and 750 ng/mL, respectively). Notably, patients in the high VCAM-1 and low BDNF group had the highest prevalence (50%) of CKD. Multivariate logistic regression revealed a significantly higher odds ratio (OR) of CKD in the high VCAM-1 and low BDNF group (OR = 3.885, 95% CI: 1.766-8.547, <i>P &lt;</i>0.001), followed by that in the high VCAM-1 and high BDNF group (OR = 3.099, 95% CI: 1.373-6.992, <i>P</i> =0.006) compared with that in the low VCAM-1 and high BDNF group. However, the risk of CKD in the low VCAM-1 and low BDNF group was not significantly different from that in the low VCAM-1 and high BDNF group (<i>P</i> =0.266).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">CKD in patients with type 2 DM is associated with low serum BDNF and high VCAM-1 levels. BDNF and VCAM-1 have a synergistic effect on CKD. Thus, BDNF and VCAM-1 can be potential biomarkers for CKD risk stratification in patients with type 2 DM.</AbstractText><CopyrightInformation>Copyright © 2024 Chiang, Li, Chan, Cheng, Wu, Lin, Huang and Lee.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chiang</LastName><ForeName>Yu-Hsin</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Education, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Chung Shan Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yu-Hsuan</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science &amp; Information Engineering, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Yin-Ching</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Food and Nutrition, Providence University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yu-Cheng</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Junyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jer-An</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Graduate Institute of Food Safety, National Chung Hsing University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Wei-Chang</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>School of Medicine, Chung Shan Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chest Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mycobacterial Center, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lee</LastName><ForeName>I-Te</ForeName><Initials>IT</Initials><AffiliationInfo><Affiliation>School of Medicine, Chung Shan Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019010">Vascular Cell Adhesion Molecule-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>7171WSG8A2</RegistryNumber><NameOfSubstance UI="C579455">BDNF protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="Y">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019010" MajorTopicYN="Y">Vascular Cell Adhesion Molecule-1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">brain-derived neurotrophic factor</Keyword><Keyword MajorTopicYN="N">chronic kidney disease</Keyword><Keyword MajorTopicYN="N">synergistic effect</Keyword><Keyword MajorTopicYN="N">type 2 diabetes mellitus</Keyword><Keyword MajorTopicYN="N">vascular cell adhesion molecule-1</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>4</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39355615</ArticleId><ArticleId IdType="pmc">PMC11442372</ArticleId><ArticleId IdType="doi">10.3389/fendo.2024.1403717</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Burden of Disease Chronic Kidney Disease Collaboration . Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the global burden of disease study 2017. Lancet. (2020) 395:709–33. doi: 10.1016/s0140-6736(20)30045-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30045-3</ArticleId><ArticleId IdType="pmc">PMC7049905</ArticleId><ArticleId IdType="pubmed">32061315</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang V, Vilme H, Maciejewski ML, Boulware LE. The economic burden of chronic kidney disease and end-stage renal disease. Semin Nephrol. (2016) 36:319–30. doi: 10.1016/j.semnephrol.2016.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2016.05.008</ArticleId><ArticleId IdType="pubmed">27475662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ríos Burrows N, Koyama A, Pavkov ME. Reported cases of end-stage kidney disease-United States, 2000-2019. Am J Transplant. (2022) 22:1483–6. doi: 10.1111/ajt.16657</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16657</ArticleId><ArticleId IdType="pubmed">35524720</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Li N, Wu Y, Wang M, Yang S, Zheng Y, et al. . Global, regional, and national burden of diabetes-related chronic kidney disease from 1990 to 2019. Front Endocrinol (Lausanne). (2021) 12:672350. doi: 10.3389/fendo.2021.672350</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.672350</ArticleId><ArticleId IdType="pmc">PMC8281340</ArticleId><ArticleId IdType="pubmed">34276558</ArticleId></ArticleIdList></Reference><Reference><Citation>
United States Renal Data System . 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States (2023). Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available online at: https://usrds-adr.niddk.nih.gov/2023/chronic-kidney-disease (Accessed March 15, 2024).</Citation></Reference><Reference><Citation>Wang T, Xi Y, Lubwama R, Hannanchi H, Iglay K, Koro C. Chronic kidney disease among us adults with type 2 diabetes and cardiovascular diseases: A national estimate of prevalence by kdigo 2012 classification. Diabetes Metab Syndr. (2019) 13:612–5. doi: 10.1016/j.dsx.2018.11.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2018.11.026</ArticleId><ArticleId IdType="pubmed">30641775</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozanska O, Uruska A, Zozulinska-Ziolkiewicz D. Brain-derived neurotrophic factor and diabetes. Int J Mol Sci. (2020) 21:841. doi: 10.3390/ijms21030841</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21030841</ArticleId><ArticleId IdType="pmc">PMC7037992</ArticleId><ArticleId IdType="pubmed">32012942</ArticleId></ArticleIdList></Reference><Reference><Citation>Davarpanah M, Shokri-Mashhadi N, Ziaei R, Saneei P. A systematic review and meta-analysis of association between brain-derived neurotrophic factor and type 2 diabetes and glycemic profile. Sci Rep. (2021) 11:13773. doi: 10.1038/s41598-021-93271-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93271-z</ArticleId><ArticleId IdType="pmc">PMC8253793</ArticleId><ArticleId IdType="pubmed">34215825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ola MS, Nawaz MI, El-Asrar AA, Abouammoh M, Alhomida AS. Reduced levels of brain derived neurotrophic factor (Bdnf) in the serum of diabetic retinopathy patients and in the retina of diabetic rats. Cell Mol Neurobiol. (2013) 33:359–67. doi: 10.1007/s10571-012-9901-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-012-9901-8</ArticleId><ArticleId IdType="pubmed">23271640</ArticleId></ArticleIdList></Reference><Reference><Citation>Azoulay D, Abed S, Sfadi A, Sheleg O, Shaoul E, Shehadeh M, et al. . Low brain-derived neurotrophic factor protein levels and single-nucleotide polymorphism val66met are associated with peripheral neuropathy in type II diabetic patients. Acta Diabetol. (2020) 57:891–8. doi: 10.1007/s00592-020-01508-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-020-01508-6</ArticleId><ArticleId IdType="pubmed">32124075</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, Sheu WH, Lee IT. Brain-derived neurotrophic factor associated with kidney function. Diabetol Metab Syndr. (2023) 15:16. doi: 10.1186/s13098-023-00991-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13098-023-00991-5</ArticleId><ArticleId IdType="pmc">PMC9926783</ArticleId><ArticleId IdType="pubmed">36782254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong DH, Kim YK, Kim MR, Jang JH, Lee S. Emerging roles of vascular cell adhesion molecule-1 (Vcam-1) in immunological disorders and cancer. Int J Mol Sci. (2018) 19:1057. doi: 10.3390/ijms19041057</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19041057</ArticleId><ArticleId IdType="pmc">PMC5979609</ArticleId><ArticleId IdType="pubmed">29614819</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankow JS, Decker PA, Berardi C, Hanson NQ, Sale M, Tang W, et al. . Circulating cellular adhesion molecules and risk of diabetes: the multi-ethnic study of atherosclerosis (Mesa). Diabetes Med. (2016) 33:985–91. doi: 10.1111/dme.13108</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.13108</ArticleId><ArticleId IdType="pmc">PMC4914403</ArticleId><ArticleId IdType="pubmed">26937608</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadel MM, Abdel Ghaffar FR, Zwain SK, Ibrahim HM, Badr EA. Serum netrin and vcam-1 as biomarker for Egyptian patients with type II diabetes mellitus. Biochem Biophys Rep. (2021) 27:101045. doi: 10.1016/j.bbrep.2021.101045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrep.2021.101045</ArticleId><ArticleId IdType="pmc">PMC8209750</ArticleId><ArticleId IdType="pubmed">34179515</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Hou H, Zhao L. The role of vcam-1 in diabetic retinopathy: A systematic review and meta-analysis. J Diabetes Complications. (2023) 37:108380. doi: 10.1016/j.jdiacomp.2022.108380</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2022.108380</ArticleId><ArticleId IdType="pubmed">36525905</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui K, George TP, Mujammami M, Isnani A, Alfadda AA. The association of cell adhesion molecules and selectins (Vcam-1, icam-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study. Front Endocrinol (Lausanne). (2023) 14:1072288. doi: 10.3389/fendo.2023.1072288</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1072288</ArticleId><ArticleId IdType="pmc">PMC9948618</ArticleId><ArticleId IdType="pubmed">36843591</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IT, Wang JS, Lee WJ, Lin SY, Fu CP, Liang KW, et al. . The synergistic effect of vascular cell adhesion molecule-1 and coronary artery disease on brain-derived neurotrophic factor. Clin Chim Acta. (2017) 466:194–200. doi: 10.1016/j.cca.2017.01.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2017.01.026</ArticleId><ArticleId IdType="pubmed">28131673</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. . A new equation to estimate glomerular filtration rate. Ann Intern Med. (2009) 150:604–12. doi: 10.7326/0003-4819-150-9-200905050-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-9-200905050-00006</ArticleId><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. . 11. Chronic kidney disease and risk management: standards of care in diabetes-2023. Diabetes Care. (2023) 46:S191–202. doi: 10.2337/dc23-S011</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc23-S011</ArticleId><ArticleId IdType="pmc">PMC9810467</ArticleId><ArticleId IdType="pubmed">36507634</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan WH, Lee MS, Chuang SY, Lin YC, Fu ML. Obesity pandemic, correlated factors and guidelines to define, screen and manage obesity in Taiwan. Obes Rev. (2008) 9 Suppl 1:22–31. doi: 10.1111/j.1467-789X.2007.00434.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-789X.2007.00434.x</ArticleId><ArticleId IdType="pubmed">18307695</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Association Of The Republic Of China T . Executive summary of the daroc clinical practice guidelines for diabetes care- 2018. J Formos Med Assoc. (2020) 119:577–86. doi: 10.1016/j.jfma.2019.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2019.02.016</ArticleId><ArticleId IdType="pubmed">30952480</ArticleId></ArticleIdList></Reference><Reference><Citation>Hang PZ, Ge FQ, Li PF, Liu J, Zhu H, Zhao J. The regulatory role of the bdnf/trkb pathway in organ and tissue fibrosis. Histol Histopathol. (2021) 36:1133–43. doi: 10.14670/hh-18-368</Citation><ArticleIdList><ArticleId IdType="doi">10.14670/hh-18-368</ArticleId><ArticleId IdType="pubmed">34327702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P, Li X, Li Y, Zhu J, Sun Y, Hong J. Mechanism of mir-365 in regulating bdnf-trkb signal axis of hfd/stz induced diabetic nephropathy fibrosis and renal function. Int Urol Nephrol. (2021) 53:2177–87. doi: 10.1007/s11255-021-02853-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-021-02853-3</ArticleId><ArticleId IdType="pubmed">33881703</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotulainen P, Hoogenraad CC. Actin in dendritic spines: connecting dynamics to function. J Cell Biol. (2010) 189:619–29. doi: 10.1083/jcb.201003008</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201003008</ArticleId><ArticleId IdType="pmc">PMC2872912</ArticleId><ArticleId IdType="pubmed">20457765</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol. (2007) 17:428–37. doi: 10.1016/j.tcb.2007.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2007.06.006</ArticleId><ArticleId IdType="pubmed">17804239</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Armelloni S, Zennaro C, Wei C, Corbelli A, Ikehata M, et al. . Bdnf repairs podocyte damage by microrna-mediated increase of actin polymerization. J Pathol. (2015) 235:731–44. doi: 10.1002/path.4484</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4484</ArticleId><ArticleId IdType="pmc">PMC4356648</ArticleId><ArticleId IdType="pubmed">25408545</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JJ, Yeoh LY, Sum CF, Tavintharan S, Ng XW, Liu S, et al. . Vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, is associated with diabetic kidney disease in asians with type 2 diabetes. J Diabetes Complications. (2015) 29:707–12. doi: 10.1016/j.jdiacomp.2015.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2015.02.011</ArticleId><ArticleId IdType="pubmed">25857767</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Y, Xu H, Yu Q, Tan L, Xiong Z. Identification and verification of vascular cell adhesion protein 1 as an immune-related hub gene associated with the tubulointerstitial injury in diabetic kidney disease. Bioengineered. (2021) 12:6655–73. doi: 10.1080/21655979.2021.1976540</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21655979.2021.1976540</ArticleId><ArticleId IdType="pmc">PMC8806788</ArticleId><ArticleId IdType="pubmed">34506229</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Huang Q, Fang M, Liu M, Guo J, Wang Z. Prognostic value of serum levels of multiple adhesion factors in patients with sepsis-induced acute kidney injury. Int Urol Nephrol. (2023) 55:1229–37. doi: 10.1007/s11255-022-03394-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-022-03394-z</ArticleId><ArticleId IdType="pmc">PMC10105682</ArticleId><ArticleId IdType="pubmed">36333626</ArticleId></ArticleIdList></Reference><Reference><Citation>Su H, Liu B, Chen H, Zhang T, Huang T, Liu Y, et al. . Lncrna anril mediates endothelial dysfunction through bdnf downregulation in chronic kidney disease. Cell Death Dis. (2022) 13:661. doi: 10.1038/s41419-022-05068-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-05068-1</ArticleId><ArticleId IdType="pmc">PMC9338026</ArticleId><ArticleId IdType="pubmed">35906216</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden E, Emiliano A, Maudsley S, Windham BG, Carlson OD, Egan JM, et al. . Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the baltimore longitudinal study of aging. PloS One. (2010) 5:e10099. doi: 10.1371/journal.pone.0010099</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010099</ArticleId><ArticleId IdType="pmc">PMC2852401</ArticleId><ArticleId IdType="pubmed">20404913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaess BM, Preis SR, Lieb W, Beiser AS, Yang Q, Chen TC, et al. . Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J Am Heart Assoc. (2015) 4:e001544. doi: 10.1161/jaha.114.001544</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.114.001544</ArticleId><ArticleId IdType="pmc">PMC4392437</ArticleId><ArticleId IdType="pubmed">25762803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, Sheu WH, Lee IT. Brain-derived neurotrophic factor reduces long-term mortality in patients with coronary artery disease and chronic kidney disease. Front Cardiovasc Med. (2022) 9:881441. doi: 10.3389/fcvm.2022.881441</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.881441</ArticleId><ArticleId IdType="pmc">PMC9253370</ArticleId><ArticleId IdType="pubmed">35800175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IT, Li YH, Sheu WH. Brain-derived neurotrophic factor during oral glucose tolerance test predicts cardiovascular outcomes. Int J Mol Sci. (2020) 21:5008. doi: 10.3390/ijms21145008</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145008</ArticleId><ArticleId IdType="pmc">PMC7404303</ArticleId><ArticleId IdType="pubmed">32679912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PT, Liao IC, Lee CH, Hsu LW, Liu PY. Expression of vascular cell adhesion molecule-1 in peripheral artery disease is enriched in patients with advanced kidney disease. Acta Cardiol Sin. (2021) 37:591–9. doi: 10.6515/acs.202111_37(6).20210701b</Citation><ArticleIdList><ArticleId IdType="doi">10.6515/acs.202111_37(6).20210701b</ArticleId><ArticleId IdType="pmc">PMC8593482</ArticleId><ArticleId IdType="pubmed">34812232</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T, Warabi E, Mann GE. Mechanisms underlying unidirectional laminar shear stress-mediated nrf2 activation in endothelial cells: amplification of low shear stress signaling by primary cilia. Redox Biol. (2021) 46:102103. doi: 10.1016/j.redox.2021.102103</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102103</ArticleId><ArticleId IdType="pmc">PMC8379703</ArticleId><ArticleId IdType="pubmed">34425388</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii H, Kono K, Nishi S. Characteristics of coronary artery disease in chronic kidney disease. Clin Exp Nephrol. (2019) 23:725–32. doi: 10.1007/s10157-019-01718-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10157-019-01718-5</ArticleId><ArticleId IdType="pmc">PMC6511359</ArticleId><ArticleId IdType="pubmed">30830548</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho E, Kim M, Ko YS, Lee HY, Song M, Kim MG, et al. . Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model. Nephrol Dial Transplant. (2013) 28:2766–78. doi: 10.1093/ndt/gft376</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gft376</ArticleId><ArticleId IdType="pubmed">24009291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabe MA, Claggett B, Burdmann EA, Desai AS, Ivanovich P, Kewalramani R, et al. . Coronary artery disease is a predictor of progression to dialysis in patients with chronic kidney disease, type 2 diabetes mellitus, and anemia: an analysis of the trial to reduce cardiovascular events with aranesp therapy (TREAT). J Am Heart Assoc. (2016) 5:e002850. doi: 10.1161/JAHA.115.002850</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.115.002850</ArticleId><ArticleId IdType="pmc">PMC4859277</ArticleId><ArticleId IdType="pubmed">27108247</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Wei N, Lu T, Zhu J, Xu G, Liu X. Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience. (2011) 172:398–405. doi: 10.1016/j.neuroscience.2010.10.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.10.054</ArticleId><ArticleId IdType="pubmed">21034794</ArticleId></ArticleIdList></Reference><Reference><Citation>Anita NZ, Zebarth J, Chan B, Wu CY, Syed T, Shahrul D, et al. . Inflammatory markers in type 2 diabetes with vs. Without cognitive impairment; a systematic review and meta-analysis. Brain Behav Immun. (2022) 100:55–69. doi: 10.1016/j.bbi.2021.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.11.005</ArticleId><ArticleId IdType="pubmed">34808290</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin KD, Hsu CC, Ou HY, Wang CY, Chin MC, Shin SJ. Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of nationwide data from 2005 to 2014. J Formos Med Assoc. (2019) 118 Suppl 2:S103–10. doi: 10.1016/j.jfma.2019.07.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2019.07.027</ArticleId><ArticleId IdType="pubmed">31477486</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YY, Lin KD, Jiang YD, Chang CH, Chung CH, Chuang LM, et al. . Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of the nationwide data for 2000-2009. J Formos Med Assoc. (2012) 111:637–44. doi: 10.1016/j.jfma.2012.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2012.09.006</ArticleId><ArticleId IdType="pubmed">23217599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong L, Wang C, Ning G, Wang W, Chen G, Wan Q, et al. . High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: findings from the China cardiometabolic disease and cancer cohort (4c) study. Diabetes Obes Metab. (2021) 23:2551–60. doi: 10.1111/dom.14502</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14502</ArticleId><ArticleId IdType="pmc">PMC9291490</ArticleId><ArticleId IdType="pubmed">34322974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaman SB, Karim MA, Hossain N, Al Kibria GM, Islam SMS. Plasma triglycerides as a risk factor for chronic kidney disease in type 2 diabetes mellitus: evidence from Northeastern Thailand. Diabetes Res Clin Pract. (2018) 138:238–45. doi: 10.1016/j.diabres.2018.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2018.02.011</ArticleId><ArticleId IdType="pubmed">29448006</ArticleId></ArticleIdList></Reference><Reference><Citation>Luk AO, Li X, Zhang Y, Guo X, Jia W, Li W, et al. . Quality of care in patients with diabetic kidney disease in asia: the joint asia diabetes evaluation (Jade) registry. Diabetes Med. (2016) 33:1230–9. doi: 10.1111/dme.13014</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.13014</ArticleId><ArticleId IdType="pubmed">26511783</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>